Neoral
Links shared publicly online about this topic
ingentaconnect Nanoparticulate Delivery Can Improve Peroral Bioavailability of C...
ingentaconnect.com — “ingentaconnect Nanoparticulate Delivery Can Improve Peroral Bioavailability of C...” View full resource at ingentaconnect.com
Most Recently Shared on April 24, 2011 at 3:41 am By:
Nanoparticulate Delivery Can Improve Peroral Bioavailability of Cyclosporine and Match Neoral Cmax Sparing the K... http://bit.ly/gVrq3Z
FDA Requires Labeling Change for Some Drugs Used to Prevent Rejection of Kidney Transplants
fda.gov — “The U.S. Food and Drug Administration today said that it will require manufacturers of some immunosuppressant drugs used in kidney (renal) transplantation to update their labeling to reflect an increased risk of infections.” View full resource at fda.gov
Most Recently Shared on July 14, 2009 at 4:05 pm By:
FDA Requires Labeling Change for Some Drugs Used to Prevent Rejection of Kidney Transplants http://bit.ly/40cOo
Comments of Liver Transplant medications and their effects - eHealthMe.com
ehealthme.com — “Your list of 3 drugs used for anti-rejection in liver transplant pts, actually consists of just 2 drugs, You have included the generic and trade names for the same drug, tacrolimus/Prograf, and you list Rapamune. You left out the real third drug- which is actually in use, the second-line drug, cyclosporin(modified)/Neoral. Pat” View full resource at ehealthme.com
Most Recently Shared on March 19, 2012 at 3:20 pm By:
Your list of 3 drugs used for anti-rejection in liver transplant pts, actually consists of just 2 drugs, You h http://t.co/qIgie9Bt
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Urology & Nephrology
Organizing urology resources shared by health experts, advocates, and organizations into WisdomCards.
-
eyeonfda
Author of the blog Eye on FDA - www.eyeonfda.com
-
eHealthMe.com
eHealthMe provides health professionals and patients personalized tools to study millions of drug reports from FDA and community in real time.
Advertisement

